The Human Variable 

Remission is often defined as symptom improvement at a single moment in time. The CYNAERA Remission Standard™ challenges that assumption by introducing a state-dependent model that evaluates stability, durability, function, flare control, and resilience over time. Applied across Long COVID, autoimmune disease, and clinical trials, this framework provides a more accurate way to measure recovery, reduce misclassification, and align outcomes with real-world patient experience.

SymCas™ is a flare prediction model for POTS, Lyme disease, ME/CFS, Long COVID and relapsing chronic conditions. It identifies symptom patterns over time to detect early instability and support proactive care.

The true U.S. burden of Lyme disease is estimated at 5 - 7 million Americans, according to CYNAERA’s US-CCUC™ 2026 prevalence model, substantially higher than the roughly 400,000 to 500,000 diagnoses recorded annually. By accounting for underdiagnosis, chronic illness, and fragmented surveillance, this paper reframes Lyme disease as a major chronic illness burden rather than a narrowly counted regional infection.

A new framework for disease prevalence estimation, the Diagnostic Multiplier™ (DM™) adjusts for underdiagnosis, diagnostic variability, and environmental exposure across conditions.

Under our CCUC™ model 650–900 million cumulative global Long COVID cases is the more realistic planning band, and the true upper burden may exceed that under ongoing reinfection and chronic invisibility. Long COVID is not a niche aftermath. It is a mass disabling event, a chronic illness multiplier, and a global systems challenge woven into labor, education, family stability, and future health burden.

Parents often notice changes in gaming before anyone else notices changes in health. A child who once enjoyed fast, demanding games may suddenly avoid them. Another may become intensely focused on one specific game or routine. Some children begin choosing calmer, slower, or more predictable games that simply feel better, even if they cannot explain why. This may be early clues inside a very large and still underrecognized pediatric infection-associated chronic illness.